Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Amicus Therapeutics, Inc.
< Previous
1
2
Next >
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
September 08, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
August 29, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates
July 31, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
July 21, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces Approval of Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in Japan
June 25, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve
June 03, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025
May 30, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
May 07, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
May 01, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
April 21, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025
February 27, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
February 19, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025
February 10, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025
February 03, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook
January 12, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 02, 2025
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates
November 06, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
November 01, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
October 28, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva
October 17, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024
October 04, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
September 03, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
September 03, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium
September 03, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
August 30, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates
August 08, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024
July 30, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product
June 04, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
May 09, 2024
From
Amicus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FOLD
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit